Rhine Biology "sell one" 160 million

After the first half of the deputy chairman You Wen-de 134 million yuan, all kinds of signs that yesterday, the Rhine Biological (002166.SZ) Chairman of the Kin Ben Jun and its concerted action Liangming also very likely has been successful in the two-tier market is 160 million yuan. Yesterday morning, the super germs this Long-lost "catalyst" makes the medical biology class stock again boiling one.　　Early, the Rhine biological jump higher than 38.12 yuan price, and this is its May except the right since the highest price, from the right after the lowest price of 13.01 yuan to 38.12, Rhine bio rose to 193%. And just yesterday, the Rhine biological daily turnover rate reached 28.74%, the 23rd time since May boarded SSE commonly known as "Billboard" Transactions Public information. As in the past, the top five sales seats appeared many such as Guotai Shanghai Jiangsu Road Sales Department, Citic Gold Tong wenling Donghui North Road Sales Department of the hot money.　　And in the sale of sales department, ranked first in the National Sea Securities Guilin Lingui County People's Road sales office on the day of the sale of up to 164 million yuan (Rhine Biological Company address is also in Guilin Lingui County). 2010 Rhine Biological Three quarterly bulletin showed that the company's top ten circulating shares of shareholders without a financial institution, the first major shareholder, chairman of the Kin Ben Jun and their concerted action Liangming each owner of the Rhine living 9.65 million tradable shares, each accounted for 7.45% of the total equity.　　The third largest shareholder holds 260,000 shares, and the remaining major shareholders are less than 170,000 shares per person. In fact, as early as September 18 this year, the Rhine biology has announced that the holding shareholder Kin Ben Jun and Liangming because of their own capital demand, plans to reduce the company's shares in the next six months, the expected sale of shares may reach or exceed the total number of shares in the company 5%, or 6.476 million shares.　　The announcement said that the chairman Kin Ben Jun and Liangming are brotherly relations, for the unanimous action person. and the transaction amount of 160 million yuan equivalent to the day of the intraday average price of 36.2 yuan, equivalent to 4.42 million shares.　　From the shareholder's shareholding, Kin Ben Jun or Liangming reduction of the possibility is very large. If so, it would be the second time in nearly a year that the Rhine bio-organism's largest shareholder has set up billions of dollars.　　May 5 This year, Rhine Biology was notified, Vice chairman You Wen-de from November 11 to April 30 this year, the total reduction of the company's shares of about 134 million yuan, accounting for 4.92% of the company's total equity.　　In the vice chairman of the reduction, the company assigned 2009 Equity, the share price in addition to the right; after less than six months to board the Exchange billboard, the well-known hot money sales department will not abandon, the share price soared nearly twice times. These are the three consecutive quarters of losses that have been reported this year.　　2010 1 ~ September The company attributable to the listed company shareholders net profit loss of 10.25 million, the year-on-year decline of 195.7%. Some analysts pointed out: "Rhine biological performance is not ideal, but the plate small, the rally fierce, hot money on every round of medicine bio Plate market rhythm turns hype, including the previous super germ market." "From the main business of the Rhine Biology, as the first unit of plant extraction industry, RhineThe main product is the production of high purity monomer and standard extract of plant functional components, such as sweet glucoside, proanthocyanidins, anthocyanins, etc. This "hot money lover" obviously has nothing to do with superbugs.